|
|
| Product | Quantum (Rs. Cr) | Long Term Rating | Short Term Rating |
| Bank Loan Ratings | 10.00 | ACUITE BB | Stable | Reaffirmed | - |
| Bank Loan Ratings | 5.00 | - | ACUITE A4+ | Assigned |
| Bank Loan Ratings | 28.00 | - | ACUITE A4+ | Reaffirmed |
| Total Outstanding | 43.00 | - | - |
| Total Withdrawn | 0.00 | - | - |
|
Rating Rationale |
|
Acuite has reaffirmed the long-term rating of 'ACUITE BB' read as (ACUITE double B) and short-term rating at 'ACUITE A4+' read as (ACUITE A four plus) on Rs.38.00 crore bank facilities of Amtrade. The outlook is ‘Stable’. Further the Acuite has assigned the short-term rating of 'ACUTIE A4+' read as (ACUITE A four plus) on Rs.5.00 crore bank facilities of Amtrade. |
| About the Company |
|
Established in 1999, Amtrade is a partnership firm based out of Mumbai, founded by Mr. Rajesh Madhavan, Mr. Gokuldas Madhavan and Mr. Suresh Madhavan. The firm specializes in international trade, engaging in the import and export of a diverse range of commodities, including textiles, fertilizers, agrochemicals, metals, minerals, construction materials, polymers, spices, agricultural products, and petroleum products. |
| Unsupported Rating |
|
Not Applicable |
| Analytical Approach |
|
Acuité has considered the standalone business and financial risk profile of Amtrade to arrive at this rating. |
| Key Rating Drivers |
| Strengths |
| Experienced management and long track record of operations |
| Weaknesses |
| Moderately Intensive working capital operations |
Rating Sensitivities
| Potential triggers (individual or collective) for an upward rating action: |
|
| Potential triggers (individual or collective) for a downward rating action: |
|
| Liquidity Position |
| Adequate |
|
The firm’s liquidity position is adequate. The firm generated net cash accruals of Rs. 2.17 Cr. in FY2025 as against debt obligation of Rs. 0.97 Cr. The firm is expected to generate NCAs of Rs. 5.50 Cr. as against debt obligations of Rs. 1.02 Cr. The working capital operations of the firm are moderately intensive marked by GCA days of 202 days in FY25 as against 174 days in FY24. The cash and bank balance stood at Rs. 0.06 Cr. as on March 31, 2025. The average utilization of the fund-based limits stood high at ~88 per cent. The current ratio of the firm stands at 1.32 times as on March 31, 2025 as against 1.44 times on March 31, 2024. |
| Outlook: Stable |
| |
| Other Factors affecting Rating |
| None |
| Particulars | Unit | FY 25 (Actual) | FY 24 (Actual) |
| Operating Income | Rs. Cr. | 126.66 | 125.03 |
| PAT | Rs. Cr. | 1.25 | 0.43 |
| PAT Margin | (%) | 0.99 | 0.34 |
| Total Debt/Tangible Net Worth | Times | 2.35 | 1.98 |
| PBDIT/Interest | Times | 1.57 | 1.36 |
| Status of non-cooperation with previous CRA (if applicable) |
| Not Applicable |
| Any other information |
| None |
| Applicable Criteria |
|
• Default Recognition :- https://www.acuite.in/view-rating-criteria-52.htm • Application Of Financial Ratios And Adjustments: https://www.acuite.in/view-rating-criteria-53.htm • Trading Entities: https://www.acuite.in/view-rating-criteria-61.htm |
| Note on complexity levels of the rated instrument |
|
| |
|
|
||||||||||||||||||||||||||||||||||||
|
| |
|
Contacts |
About Acuité Ratings & Research |
| © Acuité Ratings & Research Limited. All Rights Reserved. | www.acuite.in |
